Two different approaches for the prediction of in Vivo plasma concentration-time profile from in Vitro release data of once daily formulations of diltiazem hydrochloride

Archives of Pharmacal Research

Volumn 32, Issue 9, 2009, Pages 1317-1329

  Bendas, Ehab R ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Convolution; Diltiazem hydrochloride; Extended release; In vitro release; In vivo prediction; Wagner Nelson

Indexed keywords

ALCOHOL; CARBOMER; DILTIAZEM; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MAGNESIUM STEARATE; POLYOX 100; POVIDONE; TALC; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; COMPUTER PROGRAM; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DETERMINATION; DRUG DIFFUSION; DRUG RELEASE; IN VITRO STUDY; IN VIVO STUDY; PREDICTION; SUSTAINED DRUG RELEASE; TABLET COMPRESSION; TABLET FORMULATION;

CALCIUM CHANNEL BLOCKERS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DILTIAZEM; DRUG ADMINISTRATION SCHEDULE; HUMANS; SOLUBILITY; TABLETS;

EID: 70349558425     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1918-2     Document Type: Article

References (49)

1. D. A. Alderman 1984 A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms Int. J. Pharm. Tech. Prod. Mfr. 5 1 9 1:CAS:528:DyaL2MXksVantrw%3D
2. S. M. Al-Saidan Y. S. R. Krishnaiah S. S. Patro V. Satyanaryana 2005 In Vitro and In Vivo Evaluation of Guar Gum Matrix Tablets for Oral Controlled Release of Water-soluble Diltiazem Hydrochloride AAPS Pharm Sci Tech. 14 6 E14 21 10.1208/pt060105 (Pubitemid 41631005)
3. G. L. Amidon H. Lennernas V. P. Shah J. R. Crison 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 413 420 7617530 10.1023/A:1016212804288 1:CAS:528:DyaK2MXksVGqur8%3D
4. S. Anurag P. Ramesh 1998 Drug release evaluation of diltiazem CR preparations Int. J. Pharm. 175 95 107 10.1016/S0378-5173(98)00268-3 (Pubitemid 28487019)
5. E. R. Bendas J. W. Ayres 2008 Leaky enteric coating on ranitidine hydrochloride beads: Dissolution and prediction of plasma data Eur. J. Pharm. Biopharm. 69 977 985 18424095 10.1016/j.ejpb.2008.02.019 1:CAS:528: DC%2BD1cXpt1GqtLs%3D
6. M. T. Buckley S. M. Grant K. L. Goa D. Mc Tavish E. M. Sorkin 1990 Diltiazem - A reappraisal of its pharmacological properties and therapeutic use Drugs. 39 757 806 2191851 10.2165/00003495-199039050-00009 1:CAS:528: DyaK3cXkvFSksbc%3D
7. C. Caramella F. Ferrari M. C. Bonferoni M. E. Sangalli M. D. Di Valserra F. Feletti M. R. Galmozzi 1993 In vitro/in vivo correlation of prolonged release dosage forms containing diltiazem HCl Biopharm. Drug Dispos. 14 143 160 8453024 10.1002/bdd.2510140206 1:CAS:528:DyaK3sXitF2ksbw%3D
8. CDER (Center for Drug Evaluation and Research), Guidance for Industry Immediate Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation, CMC 5 (1995).
9. CDER (Center for Drug Evaluation and Research), Guidance for Industrial Extended Release Oral Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations, Food and Drug Administration, Rockville, MD (1997).
10. M. Chaffman R. N. Brogden 1985 Diltiazem: a review of its pharmacological properties and therapeutic efficacy Drugs 29 387 454 3891302 10.2165/00003495-198529050-00001 1:CAS:528:DyaL2MXltFGnsrg%3D
11. M. E. Chateau L. Galet Y. Soudais J. Fages 2005 Processing a detergent powder formulation: Direct compression, and high shear wet granulation followed by compression Powder Tech. 157 191 198 10.1016/j.powtec.2005.05.026 1:CAS:528:DC%2BD2MXhtVyrsLfK (Pubitemid 41435534)
12. P. Costa J. M. Sousa 2001 Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 123 133 11297896 10.1016/S0928-0987(01)00095-1 1:CAS:528:DC%2BD3MXisF2qs78%3D (Pubitemid 32288781)
13. E. Demirtük L. Öner 2003 In Vitro - In Vivo Correlations J. Pharm. Sci. 28 215 224
14. Drugs@FDA Website, Retrieved from http://www.accessdata.fda.gov/scripts/ cder/drugsatfda.
15. A. Dunne T. O'Hara J. Devane 1997 Level A in vivo-in vitro correlation: Nonlinear models and statistical methodology J. Pharm. Sci. 86 1245 1249 9383734 10.1021/js970155d 1:CAS:528:DyaK2sXmsFyms74%3D (Pubitemid 27486095)
16. N. K. Ebube A. Hikal C. M. Wyandt D. C. Beer L. G. Miller A. B. Jones 1997 Sustained release of acetaminophen from heterogeneous matrix tablets, influence of polymer ratio, polymer loading and coactive on drug release Pharm. Dev. Technol. 2 161 170 9552442 10.3109/10837459709022621 1:CAS:528: DyaK2sXjvVygsbg%3D
17. N. Follonier E. Doelker E. T. Cole 1995 Various ways of modulating the release of diltiazem hydrochloride from hot-melt extruded sustained release pellets prepared using polymeric materials J. Control. Release 36 243 250 10.1016/0168-3659(95)00041-6 1:CAS:528:DyaK2MXosVOgtLg%3D
18. E. Galia E. Nicolaides D. Horter R. Lobenberg C. Reppas B. Dressman 1998 Evaluation of various dissolution media for predicting in vivo performance of Class I and Class II drugs Pharm. Res. 15 5 698 705 9619777 10.1023/A: 1011910801212 1:CAS:528:DyaK1cXjtlWhsL8%3D (Pubitemid 28275645)
19. M. J. Ginski J. E. Polli 1999 Prediction of dissolution-absorption relationships from a dissolution /Caco-2 system Int. J. Pharm. 177 117 125 10205608 10.1016/S0378-5173(98)00330-5 1:CAS:528:DyaK1MXivVeqsQ%3D%3D (Pubitemid 29067432)
20. Gohel, M., Delvadia, R. R., Parikh, D. C., Zinzuwadia, M. M., Soni, C. D., Sarvaiya, K. G., Mehta, N. R., Joshi, B. R., and Dabhi, A. S., Simplified Mathematical Approach for Back Calculation in Wagner-Nelson Method. Pharmaceutical reviews. Vol. 3Issue 2 (2005).
21. M. C. Gohel A. F. Amin 1998 Formulation optimization of controlled release diclofenac sodium microspheres using factorial design J. Control. Release 51 115 122 9685908 10.1016/S0168-3659(97)00102-8 1:CAS:528: DyaK1cXot12mtA%3D%3D (Pubitemid 28252862)
22. Ph. Hermann S. D. Rodger G. Remones J. P. Thenot D. R. London P. L. Morselli 1983 Pharmacokinetics of Diltiazem After Intravenous and Oral Administration Eur. J. Clin. Pharmacol. 24 349 352 6861848 10.1007/BF00610053 1:CAS:528:DyaL3sXktVSis70%3D
23. N. Hidekatsu H. Chiaki A. Tetsuya O. Ichiro M. Yuji N. Susumu T. Kazuhisa K. Yuji 2007 Application of the Correlation of in Vitro Dissolution Behavior and in Vivo Plasma Concentration Profile (IVIVC) for Soft-Gel Capsules-a Pointless Pursuit? Biol. Pharm. Bull. 30 11 2221 2225 10.1248/bpb.30.2221 (Pubitemid 350097066)
24. Z. Hussein M. Friedman 1990 Release and absorption characteristics of novel theophylline sustained-release formulations. In vitro-in vivo correlation Pharm. Res. 7 1167 1171 2293217 10.1023/A:1015988410977 1:CAS:528: DyaK3cXmtlOksr4%3D
25. S. S. Hwang J. Gorsline J. Louie D. Dye D. Guinta L. Hamel 1995 In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product J. Clin. Pharmacol. 35 259 267 7608314 1:STN:280:DyaK2Mzjt1CltA%3D%3D
26. P. R. Katikaneni S. M. Upadrashia S. H. Neau A. K. Mitra 1995 Ethylcellulose matrix controlled-release tablets of a water soluble drug Int. J. Pharm. 123 119 125 10.1016/0378-5173(95)00060-V 1:CAS:528:DyaK2MXmvF2mur8%3D
27. E. Kinney R. M. Moskovitz R. F. Zelis 1981 Pharmacokinetics and pharmacology of oral diltiazem in normal volunteers J. Clin. Pharmacol. 21 337 342 7276227 1:CAS:528:DyaL3MXmtFGhsL8%3D
28. O. Korhonen H. Kanerva M. Vidgren A. Urtti J. Ketolainen 2004 Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers J. Control. Release. 95 515 520 15023462 10.1016/j.jconrel.2003.12. 026 1:CAS:528:DC%2BD2cXitVKgtr8%3D (Pubitemid 38340501)
29. R. W. Korsmeyer R. Gurny E. M. Doelker P. Buri N. A. Peppas 1983 Mechanism of solute release from porous hydrophilic polymers Int. J. Pharm. 15 25 35 10.1016/0378-5173(83)90064-9 1:CAS:528:DyaL3sXksVens7Y%3D
30. H. B. Lawrence V. B. Umesh 1988 Further considerations in correlating in vitro-in vivo data employing mean-time concept based on statistical moments Drug Dev. Ind. Pharm. 14 15-17 2143 2150
31. Martínez, L., Villalobos, R., Sánchez, M., Cruz, J., Ganem, A., and Melgoza, L. M., Monte Carlo simulations for the study of drug release from cylindrical matrix systems with an inert nucleus. Int. J. Pharm., In press (2008).
32. M. Mi-chia L. Ru-pyng L. Jen-pei 1999 Statistical Evaluations of Dissolution Similarity Statistica Sinica. 9 1011 1027
33. J. E. Mockel B. C. Lippold 1993 Zero-order release from hydrocolloid matrices Pharm. Res. 10 1066 1070 8378249 10.1023/A:1018931210396 1:STN:280:DyaK3szptFartg%3D%3D (Pubitemid 23211433)
34. P. Mojaverian E. Mojaverian C. Radwanski C. Lin P. Cho W. A. Vadino J. M. Rosen 1992 Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations Pharm. Res. 9 450 456 1495888 10.1023/A:1015823926152 1:CAS:528: DyaK38XisVWrsLg%3D
35. J. W. Moore H. H. Flanner 1996 Mathematical comparison of dissolution profiles Pharm. Technol. 20 64 74
36. K. Murata K. Noda 1993 Pharmacokinetic analysis of an oral diltiazem preparation using multifraction absorption models Pharm. Res. 10 757 762 8321842 10.1023/A:1018976203610 1:STN:280:DyaK3szhtVagtA%3D%3D (Pubitemid 23152325)
37. K. Murata H. Yamahara M. Kobayashi K. Nodak M. Samejima 1989 Pharmacokinetics of an oral sustained release diltiazem preparation J. Pharm. Sci. 78 960 963 2621582 10.1002/jps.2600781116 1:CAS:528:DyaK3cXmt1CktQ%3D%3D
38. J. Paroèiæ S. Ibriæ Z. Djuriæ M. Jovanoviæ O. I. Corrigan 2007 An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. Eur. J. Pharm. Sci. 30 264 272 10.1016/j.ejps.2006.11.010 (Pubitemid 46306170)
39. N. A. Peppas 1985 Analysis of Fickian and non-Fickian drug release from polymers Pharm. Acta Helv. 60 110 111 4011621 1:CAS:528:DyaL2MXktFWgtb8%3D
40. N. A. Peppas J. J. Sahlin 1989 A simple equation for the description of solute release, III: coupling of diffusion and relaxation Int. J. Pharm. 57 169 175 10.1016/0378-5173(89)90306-2 1:CAS:528:DyaK3cXhtVClu74%3D (Pubitemid 20011841)
41. J. E. Polli J. R. Crison G. L. Amidon 1996 Novel approach to the analysis of In vitro-in vivo relationships J. Pharm. Sci. 85 753 759 8819002 10.1021/js9503587 1:CAS:528:DyaK28XjsVais70%3D (Pubitemid 26234682)
42. T. Salsa F. Veiga M. E. Pina 1997 Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices Drug Dev. Ind. Pharm. 23 929 938 10.3109/03639049709148697 1:CAS:528:DyaK2sXmtF2qsLc%3D
43. D. Shah Y. Shah M. Rampradhan 1997 Development and evaluation of controlled release diltiazem hydrochloride microparticles using cross-linked poly(vinyl alcohol) Drug Dev. Ind. Pharm. 23 6 567 574 10.3109/03639049709149821 1:CAS:528:DyaK2sXivFyhuro%3D
44. Sinko, P. J., Martin's physical pharmacy and pharmaceutical sciences. 5th ed. USA: Lippincott Williams &Wilkins. pp. 558 (2006).
45. N. Sirisuth L. L. Augsburger N. D. Eddington 2002 Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation Biopharm. Drug Dispos. 23 1 8 11891668 10.1002/bdd.270 1:CAS:528:DC%2BD38Xis1Wrs70%3D (Pubitemid 34256937)
46. N. Sirisuth N. D. Eddington 2002 The influence of first pass metabolism on the development and validation of an IVIVC for metoprolol extended release tablets Eur. J. Pharm. Biopharm. 53 301 309 11976018 10.1016/S0939-6411(01) 00248-X 1:CAS:528:DC%2BD38XjtVeitrw%3D (Pubitemid 34308440)
47. Staniforth, J. N., Pharmaceutics: The Science of Dosage Form Design, ed. Aulton, M.E., Livingstone: Churchill, pp. 610 (1988).
48. USP XXX, The United States Pharmacopeia/The National Formulary. United States Pharmacopeial Convention Inc., Rockville, USA (2007).
49. J. G. Wagner E. Nelson 1964 Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single dose of drugs J. Pharm. Sci. 53 1392 1403 14253604 10.1002/jps.2600531126 1:CAS:528:DyaF2MXhvVSiuw%3D%3D